Abstract
As prior fracture is consistently associated with increased risk of subsequent fracture, subjects with a history of prior fracture represent a high risk group which should be targeted for intervention to reduce future fracture rates. The aim of this study was to investigate whether prior osteoporotic fracture affected treatment patterns among subjects admitted with hip fractures. All hip fracture admissions to two major teaching hospitals of the University of New South Wales, Sydney, Australia, over the 12-month period between July 1997 and June 1998 were identified retrospectively from medical records. Patient demographics, frequency and location of prior fractures, and treatment status on admission were recorded. There were a total of 348 atraumatic hip fracture admissions over this 12-month period. Forty five percent of 251 women and 30% of 97 men with an osteoporotic hip fracture had a known prior fracture, including prior hip fracture in 19% of the women and 8% of the men. Among subjects with prior fractures, only18% of women and 7% of men were on any specific anti-osteoporosis therapy. Even among those with a prior hip fracture, only 21% of women and none of the men were taking optimal appropriate therapy. A high proportion of individuals suffering hip fractures had sustained prior "signal" fractures. Although more subjects with prior fracture received treatment than those without prior fracture, total treatment levels were low, and the majority of high-risk subjects did not receive therapy shown to reduce the risk of further fractures.
Similar content being viewed by others
References
Sanders KM, Nicholson GC, Ugoni AM, Pasco JA, Seeman E, Kotowicz MA (1999) Health burden of hip and other fractures in Australia beyond 2000. Med J Aust 170:467–470
Randell A, Sambrook PN, Nguyen TV, Lapsley H, Jones G, Kelly PJ, Eisman JA (1995) Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporos Int 5:427–432
Ray NF, Chan JK, Thamer M, Melton LJI (1997) Medical expenditures for the treatment of osteoporotic fractures in the US in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24–35
Cummings SR, Black DM, Nevitt MC (1993) Longterm fracture prediction by bone mineral density assessed at different sites. J Bone Miner Res 8:1227–1233
Johnston CC, Jr, Slemenda CW, Melton LJ III (1991) Clinical use of bone densitometry. N Engl J Med 324:1105–1109
Tosteson AN, Rosenthal DI, Melton LJI, Weinstein MC (1990) Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Int Med 113:594–603
Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259
Kotowicz MA, Melton LJ, III, Cooper C, Atkinson EJ, O'Fallon WM, Riggs BL (1994) Risk of hip fracture in women with vertebral fracture. J Bone Miner Res 9:599–605
Black DM, Arden NK, Palermo L, Pearson J, Cummings SR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res 14:821–828
Johansson C, Mellstrom D (1996) An earlier fracture as a risk factor for new fracture and its association with smoking and menopausal age in women. Maturitas 24:97–106
Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. N Engl J Med 332:767–773
Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–727
Liberman U, Weiss SR, Broll J (1995) Effect of oral alendronate on bone mineral density and incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437–1443
Cummings SR, Black DM, Thompson DE (1998) Effect of oral alendronate on risk of fracture in women in women with low bone density but without vertebral fractures—results from F.I.T. JAMA 280:2077–2082
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, McUnier PJ (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637–1642
McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster J-Y (2001) Effect of risendronate on the risk of hip fracture in elderly women. N Engl J Med 344:333–340
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288:321–333
Jones G, Nguyen T, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA (1994) Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study. Osteoporos Int 4:277–282
Jonsson B, Kanis J, Dawson A, Oden A, Johnell O (1999) Effect and offset of treatments for hip fracture on health outcomes. Osteoporos Int 10:193–199
Lips P (1997) Epidemiology and predictors of fractures associated with osteoporosis. Am J Med 103:3S–8S
Eiken P, Kolthoff N (1995) Compliance with longterm oral hormone replacement therapy. Maturitas 22:97–103
Wren B, Brown L (1991) Compliance with hormonal replacement therapy. Maturitas 13:17021
Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535–1541
Suarez-Almazor M, Homik JE, Messina D, Davis P (1997) Attitudes and beliefs of family physicians and gynaecologists in relation to the prevention and treatment of osteoporosis. J Bone Miner Res 12:1100–1107
Brennan NJ, Caplan GA (1999) Attitudes to osteoporosis and hormone replacement therapy among elderly women. Osteoporos Int 9:139–143
Garton M, Reid D, Rennie E (1995) The climacteric, osteoporosis and hormone replacement; views of women aged 45–49. Maturitas 21:7–15
Rubin SM, Cummings SR (1992) Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Int Med 116:990–995
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878–882
Edwards BJ, Bunta A, Fitzpatrick L, Bolander M, Simonelli C (2002) Hip, wrist and lower extremity fractures predict the development of future hip fractures. J Bone Miner Res 17:5461
Torgerson DJ, Dolan P (1998) Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 57:378–379
Broy SB, Bohren A, Harrington T, Licata A, Shewman D (2000) Are physicians treating osteoporosis after hip fracture? J Bone Miner Res 15:5141
Cuddihy MMP, Gabriel SE, Crowson C, Atkinson E, Melton LJI (2000) Osteoporosis management in postmenopausal women after low impact distal forearm fracture: a missed opportunity. J Bone Miner Res 15:5187
Acknowledgements
This project was funded by grants from the Royal Australian College of General Practitioners (L.P.) and from the National Health and Medical Research Council of Australia (J.E.). All authors were involved in the study design, interpretation of results and contributed to writing of the manuscript. All data were collected by one author (L.P.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Port, L., Center, J., Briffa, N.K. et al. Osteoporotic fracture: missed opportunity for intervention. Osteoporos Int 14, 780–784 (2003). https://doi.org/10.1007/s00198-003-1452-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-003-1452-x